Patent US3849388A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3849388A Expired / Lapsed US ⏱️ 0.0 years remaining

Analogues of human thyrocalcitonin

Assignee: Novartis Corp
•
Filing: 1972-09-28
•
Granted: 1974-11-19
•
Expires: 1992-09-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 1. PEPTIDES OF THE FORMULA I H-CYS-GLY-ASN-LEU-SER-THR-CYS-MET-LEU-GLY-THR-TYR-THR-GLNASP-PHE-ASN-LYS-PHE-HIS-THR-PHE-PRO-GLN-THR-ALA-ILEGLY-VAL-GLY-ALA-PRO-NH2, WHERE THE CYS RESIDUES ARE JOINED, IN WHICH THE AMINOACID IN POSITION 8 IS REPLACED BY VALINE, NORVALINE, LEUCINE, ISOLEUCINE, NORLEUCINE OR A-AMINOBYTYRIC ACID, AND THOSE WHICH CONTAIN GLYCINE IN POSITION 12 AND THOSE WHICH CONTAIN METHIONINE IN POSITION 8 AND GLYCINE IN POSITIONS 12 AND 18, OR AT LEAST IN POSITION 12, THEIR ANTIPARALLEL DIMER AND NA-ACYL DERIVATIVES WHEREIN ACRYL IS LOWER MONOBASIC OR DIBASIC ALKANOYL, LOWER ALKYLOXYCARBONYL, BENZYLOXYCARBONYL, L-PYROGLUTAMYL, CARBAMOYL, N-LOWER ALKYLCARBAMOYL, N-PHENYLCARBAMOYL, OR N-PHENYLTHIOCARBAMOYL, OR DESAMINO1-DERIVATIVES OF THE MONOMERIC OR DIMERIC PEPTIDES, AS WELL AS THERAPEUTICALLY ACCEPTABLE ACID ADDITIONS SALTS AND COMPLEXES WITH A MEMBER SELECTED FROM THE GROUP CONSISTING OF ZINC PHOSPHATE, ZINC PYROPHOSPHATE, ZINC HYDROXIDE, GELATINE, POLYPHLORETIN PHOSPHATE AND POLYGLUTAMIC ACID, OF THE SAID MONOMERIC OR DIMERIC PEPTIDES WITH THE PROVISO THAT ALL AMINOACID RESIDURS OTHER THAN GLYCINE ARE TO THE L-CONFIGURATION.

Inventors

  • 👤 W Rittel
  • 👤 H Greven
  • 👤 B Riniker
  • 👤 P Sieber
  • 👤 M Brugger
  • 👤 B Kamber

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 17:40
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/585; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 143 words
PEPTIDES OF THE FORMULA I H-CYS-GLY-ASN-LEU-SER-THR-CYS-MET-LEU-GLY-THR-TYR-THR-GLNASP-PHE-ASN-LYS-PHE-HIS-THR-PHE-PRO-GLN-THR-ALA-ILEGLY-VAL-GLY-ALA-PRO-NH2, WHERE THE CYS RESIDUES ARE JOINED, IN WHICH THE AMINOACID IN POSITION 8 IS REPLACED BY VALINE, NORVALINE, LEUCINE, ISOLEUCINE, NORLEUCINE OR A-AMINOBYTYRIC ACID, AND THOSE WHICH CONTAIN GLYCINE IN POSITION 12 AND THOSE WHICH CONTAIN METHIONINE IN POSITION 8 AND GLYCINE IN POSITIONS 12 AND 18, OR AT LEAST IN POSITION 12, THEIR ANTIPARALLEL DIMER AND NA-ACYL DERIVATIVES WHEREIN ACRYL IS LOWER MONOBASIC OR DIBASIC ALKANOYL, LOWER ALKYLOXYCARBONYL, BENZYLOXYCARBONYL, L-PYROGLUTAMYL, CARBAMOYL, N-LOWER ALKYLCARBAMOYL, N-PHENYLCARBAMOYL, OR N-PHENYLTHIOCARBAMOYL, OR DESAMINO1-DERIVATIVES OF THE MONOMERIC OR DIMERIC PEPTIDES, AS WELL AS THERAPEUTICALLY ACCEPTABLE ACID ADDITIONS SALTS AND COMPLEXES WITH A MEMBER SELECTED FROM THE GROUP CONSISTING OF ZINC PHOSPHATE, ZINC PYROPHOSPHATE, ZINC HYDROXIDE, GELATINE, POLYPHLORETIN PHOSPHATE AND POLYGLUTAMIC ACID, OF THE SAID MONOMERIC OR DIMERIC PEPTIDES WITH THE PROVISO THAT ALL AMINOACID RESIDURS OTHER THAN GLYCINE ARE TO THE L-CONFIGURATION.
Claim 2
Dependent Claim 143 words
PEPTIDES OF THE FORMULA I H-CYS-GLY-ASN-LEU-SER-THR-CYS-MET-LEU-GLY-THR-TYR-THR-GLNASP-PHE-ASN-LYS-PHE-HIS-THR-PHE-PRO-GLN-THR-ALA-ILEGLY-VAL-GLY-ALA-PRO-NH2, WHERE THE CYS RESIDUES ARE JOINED, IN WHICH THE AMINOACID IN POSITION 8 IS REPLACED BY VALINE, NORVALINE, LEUCINE, ISOLEUCINE, NORLEUCINE OR A-AMINOBYTYRIC ACID, AND THOSE WHICH CONTAIN GLYCINE IN POSITION 12 AND THOSE WHICH CONTAIN METHIONINE IN POSITION 8 AND GLYCINE IN POSITIONS 12 AND 18, OR AT LEAST IN POSITION 12, THEIR ANTIPARALLEL DIMER AND NA-ACYL DERIVATIVES WHEREIN ACRYL IS LOWER MONOBASIC OR DIBASIC ALKANOYL, LOWER ALKYLOXYCARBONYL, BENZYLOXYCARBONYL, L-PYROGLUTAMYL, CARBAMOYL, N-LOWER ALKYLCARBAMOYL, N-PHENYLCARBAMOYL, OR N-PHENYLTHIOCARBAMOYL, OR DESAMINO1-DERIVATIVES OF THE MONOMERIC OR DIMERIC PEPTIDES, AS WELL AS THERAPEUTICALLY ACCEPTABLE ACID ADDITIONS SALTS AND COMPLEXES WITH A MEMBER SELECTED FROM THE GROUP CONSISTING OF ZINC PHOSPHATE, ZINC PYROPHOSPHATE, ZINC HYDROXIDE, GELATINE, POLYPHLORETIN PHOSPHATE AND POLYGLUTAMIC ACID, OF THE SAID MONOMERIC OR DIMERIC PEPTIDES WITH THE PROVISO THAT ALL AMINOACID RESIDURS OTHER THAN GLYCINE ARE TO THE L-CONFIGURATION.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1977-11-18 1978-05-20 1978-11-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1981-11-18 1982-05-20 1982-11-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1985-11-18 1986-05-20 1986-11-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag